The first plasmodium vivax relapses of life are usually genetically homologous

Journal of Infectious Diseases

Volumn 205, Issue 4, 2012, Pages 680-683

  Imwong, Mallika ^a   Boel, MacHteld E ^a,b   Pagornrat, Watcharee ^a   Pimanpanarak, Mupawjay ^b   McGready, Rose ^a,b,c   Day, Nicholas P J ^a,c   Nosten, Franois ^a,b,c   White, Nicholas J ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMAQUINE;

CLINICAL ARTICLE; COHORT ANALYSIS; ENDEMIC DISEASE; FOLLOW UP; GENOTYPE; HUMAN; INFANT; MALE; MICROSATELLITE MARKER; MOTHER; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RECURRENT INFECTION; RELAPSE; REVIEW; THAILAND;

ADULT; ALLELES; COHORT STUDIES; DNA, PROTOZOAN; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, VIVAX; MICROSATELLITE REPEATS; MOLECULAR TYPING; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PREGNANCY; PROSPECTIVE STUDIES; RECURRENCE;

EID: 84856249714     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir806     Document Type: Review

References (15)

1. Looareesuwan S, Wilairatana P, Krudsood S, et al. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol 1999; 93:225-30. (Pubitemid 29355870)
2. Luxemburger C, van Vugt M, Jonathan S, et al. Treatment of vivax malaria on the western border of Thailand. Trans R Soc Trop Med Hyg 1999; 93:433-8. (Pubitemid 29405879)
3. Silachamroon U, Krudsood S, Treeprasertsuk S, et al. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg 2003; 69:14-18.
4. Smithuis F, Kyaw MK, Phe O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 2010; 10:673-81.
5. Douglas NM, Nosten F, Ashley EA, et al. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis 2011; 52:612-20.
6. Coatney GR, Cooper WC, Young MD. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malar Soc 1950; 9:381-96.
7. Schmidt LH, Fradkin R, Genther CS, Rossan RN, SquiresW, Hughes HB. Plasmodium cynomolgi infections in the rhesus monkey. Am J Trop Med Hyg 1982; 31:609-703.
8. Imwong M, Snounou G, Pukrittayakamee S, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis 2007; 195:927-33. (Pubitemid 46452096)
9. Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis 2007; 195:934-41. (Pubitemid 46452097)
10. Restrepo E, Imwong M, Rojas W, Carmona-Fonseca J, Maestre A. High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia. Acta Trop 2011; 119:23-9.
11. Swellengrebel NH, De Buck A. Malaria in the Netherlands. Amsterdam: Scheltema & Holkema, 1938.
12. Gunawardena S, Karunaweera ND, Ferreira MU, et al. Geographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia. Am J Trop Med Hyg 2010; 82:235-42.
13. Imwong M, Nair S, Pukrittayakamee S, et al. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. Int J Parasitol 2007; 37:1013-22. (Pubitemid 46887595)
14. Anderson TJ, Haubold B, Williams JT, et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 2000; 17:1467-82.
15. Imwong M, Nakeesathit S, Day NP,White NJ. A review of mixedmalaria species infections in anopheline mosquitoes. Malar J 2011; 10:253.